The Stanford Law School blog recently highlighted the collaboration between Stanford law students and PharmGKB to write a response to the FDA proposed regulation of laboratory developed tests.
Read more about the Juelsgaard Intellectual Property and Innovation Clinic students and their work.
No comments:
Post a Comment